Religare Enterprises

The Burman family has increased its stake in Religare Enterprises Limited to 30.3% through recent acquisitions. This move precedes the demerger of Care Health Insurance, aiming to streamline business and enhance growth opportunities for both financial services and insurance sectors.

Even though the demerger promises the unlocking of shareholder value, Religare Enterprises investors were not impressed. REL has corrected by 9% since 14 February, bringing the stock close to its support level.

Stock market today: On Friday, the Sensex tumbled 1,048 points, or 1.25%, to end at 82,626.76, while the Nifty 50 dropped 336 points, or 1.30%, to settle at 25,471.10.

Religare Enterprises will retain its stake in Care Health Insurance. The financial services business, comprising lending, broking, investment and ancillary and support services, will be transferred to Religare Finvest ‘on a going concern basis’.

Burman family-backed Religare Enterprises share price is set to be in focus market investors on Monday, 16 February 2026 after the company's board approved its demerger plans. Here's what investors need to know about demerger details and share price movement.

Buy or sell: Vaishali Parekh recommends three intraday stocks for today — Delhivery, Religare Enterprises, DLF

Stocks to buy: Regarding intraday stocks for today, Vaishali Parekh of Prabhudas Lilladher recommends three stocks to buy: Natco Pharma, Religare Enterprises and Himatsingka Seide.

InGovern has sought details on the recovery of shares worth ₹ 480 crore from Rashmi Saluja and questioned the legitimacy of employee share options after IRDAI's disapproval.